Quartic.ai, Sparta Systems partner on ‘smart’ manufacturing tech

By Jenni Spinner contact

- Last updated on GMT

(gorodenkoff/iStock via Getty Images Plus)
(gorodenkoff/iStock via Getty Images Plus)

Related tags: Artificial intelligence, Manufacturing, Risk

The two companies are collaborating on AI-enabled risk detection, intended to increase pharma product quality and process efficiency.

Quartic.ai is joining forces with Sparta Systems to develop artificial intelligence (AI) based solutions to detect risks early in the pharmaceutical manufacturing process. The goal is to come up with solutions that can help reduce product quality impact, and enable near-real-time product release.

Getting a handle on quality output during the manufacturing of pharmaceutical products is crucial to drug companies and their production partners. However, because quality cannot be fully controlled, the process relies on detection of and reaction to risk and problems to safeguard product quality.

Dana Jones, CEO of Sparta Systems, said the joint effort ultimately will provide users with “meaningful” insights and intelligence.

The ability to not only capture but distribute the information to all levels and across all operating units empowers our customers to make faster and better decisions while assuring the quality of medical products and safety of patients and users​,” she said.

Working with Quartic.ai’s AI and IoT Platform, Sparta’s TrackWise and TrackWise Digital will collect production equipment data during development, in order to create and ‘train’ algorithms that detect product and process anomalies. Once the product is completely developed and given the go-ahead for commercial distributions, users reportedly will be able to deploy these algorithms to pinpoint performance anomalies before time and materials are wasted on noncomforming product.

In the event performance ‘drift’ is detected, the two platforms working together will create a a record, pair it and provide operators with development insights, and deliver instructions on correcting issues. The process is designed to avoid issues and under-informed production decisions.

Rajiv Anand, Quartic.ai CEO, said the collaboration will harness the integrated sensors of processing and manufacturing equipment, and use AI and machine-learning tools to prevent deviations.

The ultimate goal is to be certain that all critical parameters are met, that we capture process and human knowledge, and that we are certain product coming off the line is not just ok, but perfect - the absolute highest quality​,” Anand explained.

Related news

Show more

Related products

show more

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more